- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.08. | Ortivus AB Ser. B Q2 Loss Decreases | 1 | RTTNews | ||
| 25.08. | Ortivus AB: Interim Report for Ortivus AB (publ) for the period April - June 2026 | 123 | GlobeNewswire (Europe) | "Ortivus' deep domain knowledge and advancements in AI mean that we, with the MobiMed platform, are well positioned to meet the healthcare sector's urgent need for increased efficiency."
April-June... ► Artikel lesen | |
| 07.05. | Ortivus AB: Interim Report for Ortivus AB (publ) for the period January-March 2026 | 212 | GlobeNewswire (Europe) | "We are fully embracing AI, both in our products and in our internal operations."
January-March 2026 Net sales increased with 18% and amounted to SEK 21.5 (18.1) million.The gross margin increased to... ► Artikel lesen | |
| 04.05. | Ortivus AB: Ortivus AB completes sale of its holding in H&E Solutions AB and realises a profit | 183 | GlobeNewswire (Europe) | Ortivus AB today announces that it has completed the sale of its entire shareholding in the technology company H&E Solutions AB (Evam) for a purchase price of SEK 5.2 million. The transaction results... ► Artikel lesen | |
| 21.04. | Ortivus AB: Ortivus AB welcomes Matti Zemack as new Chief Product Officer | 297 | GlobeNewswire (Europe) | Ortivus is pleased to announce the appointment of Matti Zemack as the new Chief Product Officer (CPO). In this strategic role, Zemack will lead the company's product vision and development, driving... ► Artikel lesen | |
| 31.03. | Ortivus AB: Ortivus strengthens liquidity to accelerate the company's growth strategy | 184 | GlobeNewswire (Europe) | Ortivus is enabling increased investment in its growth strategy by further strengthening its financial position with an additional loan of SEK 5 million, following the full utilisation of the SEK 20... ► Artikel lesen | |
| 19.02. | Ortivus AB: Year-end Report January - December 2025 | 304 | GlobeNewswire (Europe) | "We enter 2026 with a strengthened balance sheet, a more efficient organisation, and a portfolio of innovations already making a difference."
October-December 2025Net sales decreased by 12% and amounted... ► Artikel lesen | |
| 13.01. | The observation status for Ortivus AB is removed | 455 | GlobeNewswire | On December 2, 2025, the shares in Ortivus AB (the "Company") were given observation status with reference to a mandatory public offer from Ponderus Invest AB to the other shareholders in Ortivus... ► Artikel lesen | |
| ORTIVUS Aktie jetzt für 0€ handeln | |||||
| 13.01. | Ortivus AB: Ortivus informs that Ponderus Invest AB has announced the final outcome of the mandatory cash offer to the shareholders of Ortivus Aktiebolag | 258 | GlobeNewswire (Europe) | Ponderus Invest AB ("Ponderus") announced on 2 December 2025 a mandatory cash offer to the shareholders of Ortivus Aktiebolag ("Ortivus" or the "Company") to transfer all of their shares in Ortivus... ► Artikel lesen | |
| 22.12.25 | Ortivus AB: Ortivus informs that Ponderus Invest AB has announced approval from the Swedish Inspectorate of Strategic Products regarding the mandatory cash offer to the shareholders of Ortivus Aktiebolag | 216 | GlobeNewswire (Europe) | Ponderus Invest AB ("Ponderus") announced on 2 December 2025 a mandatory cash offer to the shareholders of Ortivus Aktiebolag ("Ortivus") to transfer all of their shares in Ortivus to Ponderus for SEK... ► Artikel lesen | |
| 18.12.25 | Ortivus AB: The independent bid committee of Ortivus unanimously recommends that shareholders do not accept the mandatory cash offer submitted by Ponderus Invest AB | 309 | GlobeNewswire (Europe) | The independent bid committee of Ortivus AB (publ) ("Ortivus" or the "Company") unanimously recommends that shareholders of Ortivus do not accept the mandatory cash offer submitted by Ponderus Invest... ► Artikel lesen | |
| 17.12.25 | Ortivus AB: Ortivus welcomes Minni Raij as new CFO | 270 | GlobeNewswire (Europe) | Ortivus is pleased to announce the appointment of Minni Raij as the new Chief Financial Officer (CFO) at Ortivus. Minni brings more than two decades of experience in finance and management. Minni will... ► Artikel lesen | |
| 02.12.25 | Ortivus AB receives observation status | 211 | GlobeNewswire | Today, December 2, 2025, Ponderus Invest AB disclosed a mandatory public offer to the other shareholders in Ortivus AB.
The rules of Nasdaq First North Growth Market state that an issuer may... ► Artikel lesen | |
| 02.12.25 | Ortivus AB: Ortivus announces mandatory public offer from Ponderus Invest AB | 206 | GlobeNewswire (Europe) | On 14 November 2025, Ponderus Invest AB announced its intention to return no later than 3 December 2025 with information regarding a potential mandatory public offer to the shareholders of Ortivus AB... ► Artikel lesen | |
| 28.11.25 | Ortivus AB: Interim Report for Ortivus AB (publ) for the period July - September 2025 | 340 | GlobeNewswire (Europe) | "The increased interest we are witnessing in the market and from existing customers, together with the high pace of our product development, gives us a positive outlook for the future."
July-September... ► Artikel lesen | |
| 14.11.25 | Ortivus AB: Ortivus Informs About A Possible Mandatory Bid From Ponderus Invest | 223 | GlobeNewswire (Europe) | Ortivus Aktiebolag ("Ortivus" or the "Company") resolved at an extraordinary general meeting on September 19, 2025 to carry out a fully guaranteed rights issue of B shares corresponding to an issue... ► Artikel lesen | |
| 15.10.25 | Ortivus AB: Ortivus announces that CFO Johan Wewel has decided to leave his position | 220 | GlobeNewswire (Europe) | Ortivus announces today that the company's CFO, Johan Wewel, has decided to leave his position to take up a role outside the Group. Johan Wewel will remain in his current position until 7 January 2026... ► Artikel lesen | |
| 30.09.25 | Ortivus AB: Ortivus publishes information document regarding Rights Issue of shares | 225 | GlobeNewswire (Europe) | THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 19.09.25 | Ortivus AB: Press release from the Extraordinary General Meeting of Ortivus AB regarding Rights Issue | 338 | GlobeNewswire (Europe) | At the Extraordinary General Meeting of Ortivus AB (publ), held in Danderyd on 19 September 2025, the following resolutions were adopted.
For more detailed information, please refer to the full notice... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 45,705 | +0,75 % | AKTIE IM FOKUS: Fresenius ziehen an Dax-Spitze - UBS äußert sich zuversichtlich | FRANKFURT (dpa-AFX) - Die Aktien von Fresenius haben am Dienstag von einem positiven Analystenkommentar profitiert und so vorerst eine achttägige Verlustserie beendet. Die Papiere des Medizinkonzerns... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,990 | -0,49 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Siemens Healthineers auf "Overweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,560 | -0,13 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| HEARTFLOW | 49,540 | -0,68 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,27 | 0,00 % | BrightSpring Health Services auf Jefferies-Konferenz: Wachstum auf breiter Front | ||
| ALIGNMENT HEALTHCARE | 12,935 | +2,58 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| BASEL MEDICAL GROUP | 7,180 | 0,00 % | Morning Market Movers: Aehr Test Systems, Pentair, NextCure, Basel Medical Group See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 14,395 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,390 | +3,20 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 21,025 | +3,22 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| CARL ZEISS MEDITEC | 30,280 | -2,38 % | 589 Millionen Menschen mit Diabetes: Warum die globale Diabetes-Welle zum Technologiethema für die Augen wird - und wo Rise Nano Optics ins Spiel kommt | ||
| STARLING ONCOLOGY INSTITUTE | 6,520 | +5,67 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| GENEDX | 89,77 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| BETA BIONICS | 16,710 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| GERRESHEIMER | 27,500 | -2,62 % | EQS-DD: Gerresheimer AG: Active Ownership Opportunities SCS, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
11.09.2026 / 20:31... ► Artikel lesen |
ORTIVUS AB gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ORTIVUS AB finden Sie auf Wallstreet Online.